ArticleJournal for immunotherapy of cancer2024
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC.
Yachang Huo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it